Previous Meetings

GBCC 2016

Global Breast Cancer Conference 2016

07:30-08:10
Breakfast Symposium 1
Venue: Halla Hall
  • Getting Targeted Therapy Development Up-to-date in Breast Cancer
    Joohyuk Sohn (Yonsei Cancer Center, Korea)
08:30-09:30
Plenary Lecture 3
Venue: Halla Hall
  • Maximizing Cosmetic and Oncologic Outcomes with Oncoplastic Techniques
    Jean-Yves Petit (European Institute of Oncology, Italy)
09:40-10:50
Symposium 3
Additional Imaging Modality for the Management of Breast Cancer Patients
Venue: Halla Hall
  • How to Use Magnetic Resonance Imaging Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Nariya Cho (Seoul National Univ. College of Medicine, Seoul National Univ. Hospital, Korea)
  • Current Role and Challenge of PET-CT in Breast Cancer
    Sung-Eun Kim (Korea Univ. Anam Hospital, Korea)
  • PET/MR in Breast Cancer
    Sang Moo Lim (Korea Institute of Radiological & Medical Sciences, Korea)
Symposium 4
Breast Cancer Survivorship in Precision Medicine Era
Venue: Lotus Hall
  • Influence of Lifestyle Factors on Breast Cancer Prognosis
    Xiao-Ou Shu (Vanderbilt Univ., U.S.A.)
  • Evidence that Germline Genetic Factors Influence Survivorship from the Australian Breast Cancer Family Study
    John Hopper (Univ. of Melbourne, Australia)
  • Quality Adjusted Life Years Loss due to Breast Cancer in Korea
    Min-Woo Jo (Univ. of Ulsan College of Medicine, Korea)
11:00-12:10
Symposium 5
Role of Cytotoxic Chemotherapy in the Era of Personalized Medicine
Venue: Halla Hall
  • Nab-Paclitaxel in Breast Cancer: Clinical Development and Future Directions
    Stefan Glück (Celgene Corporation, U.S.A.)
  • Eribulin Mesylate in the Management of Metastatic Breast Cancer
    Alison Jones (Leaders in Oncology Care, United Kingdom)
  • Non-Anthracycline Adjuvant Chemotherapy
    Yee Soo Chae (Kyungpook National Univ. Medical Center, Korea)
Symposium 6
Potential of Overcoming Resistance to HER2-targeted Therapies
Venue: Lotus Hall
  • PIK3CA Mutations in HER2-positive Breast Cancer
    Seock-Ah Im (Seoul National Univ. Hospital, Korea)
  • Overcoming HER2 Targeted Therapy: Ongoing Challenge
    Yoon Sim Yap (National Cancer Centre Singapore, Singapore)
  • Precision Medicine Guided by Single-molecule Imaging
    Tae-Young Yoon (Yonsei Univ., Korea)
Survivorship Session
Advanced Care and Research in Breast Cancer Survivorship
Venue: Weolla Room
  • Communication and Unmet Needs of Patients/Families/Caregivers
    Juhee Cho (Sungkyunkwan Univ. School of Medicine, Korea)
  • Patient Navigation Services for Breast Cancer Survivors
    Jung-Won Lim (Kangnam Univ., Korea)
  • M-Health Application beyond Quality of Life for Breast Cancer Survivors
    Jong Won Lee (ASAN Medical Center, Korea)
12:10-13:10
Luncheon Symposium 2
Venue: Halla Hall
  • Rethinking Neoadjuvant Therapy: Neoadjuvant Therapy as a Platform for Drug Development in HER2 Positive Breast Cancer
    Jee Hyun Kim (Seoul National Univ. Bundang Hospital, Korea)
13:10-14:50
Nursing Session
Current Issues for Management of Breast Cancer Treatment
Venue: Weolla Room
  • Nursing Care in Endocrine Therapy
    Jung A Do (Cheil General Hospital & Women's Healthcare Center, Korea)
  • Chemotherapy-related Cognitive Function in Patients with Breast Cancer
    Jin-Hee Park (Ajou Univ. College of Nursing, Korea)
  • Chemotherapy Induced Peripheral Neuropathy Breast Cancer Patients
    Mi Sook Han (Inha Univ. Hospital, Korea)
  • Nursing Care in Cardiotoxicity
    Onam Ok (Samsung Medical Center, Korea)
  • Nursing Management for Patients with Advanced Breast Cancer Wound
    Hyun Seo (Ewha Womans Univ. Mokdong Hospital, Korea)
13:30-14:30
Plenary Lecture 4
Venue: Halla Hall
  • What Is the Next Goal of HER-2 Targeted Therapy
    Hope Rugo (Univ. of California San Francisco Medical Center, U.S.A.)
14:30-15:50
Panel Discussion 3
What Is the Best in Breast Cancer Surgery?
Venue: Lotus Hall
  • Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer: To do or Not to do
    Byung Ho Son (ASAN Medical Center, Univ. of Ulsan College of Medicine, Korea)
  • Minimally Invasive, Maximal Outcomes in Breast Surgery
    Eun Sook Lee (National Cancer Center, Korea)
  • Cavity Shave Margins: Method and Impact on Practice
    Anees Cagpar (Yale Univ. School of Medicine, U.S.A.)
14:40-15:50
Symposium 7
Challenging Treatment for TNBC
Venue: Halla Hall
  • Molecular Heterogeneity of TNBC and Methods of Classification
    Joon Jeong (Gangnam Severance Hospital, Yonsei Univ., Korea)
  • The Future of Personalized Therapy in Triple-negative Breast Cancer
    Masakazu Toi (Kyoto Univ. Hospital, Japan)
  • New Treatment Directions for Triple-negative Breast Cancer
    Naoto Ueno (The Univ. of Texas, MD Anderson Cancer Center, U.S.A.)
16:00-17:20
ABRCA & HBOC
Venue: Lotus Hall
  • Precision Medicine for Cancer: the BRCA1/2 Paradigm
    Timothy Rebbeck (Harvard TH Chan School of Public Health and Dana Farber Cancer Institute, U.S.A.)
  • Management of Hereditary Breast Cancer: Advances and Controversies
    Ava Kwong (The Univ. of Hong Kong, Hong Kong)
  • Gene-panel Sequencing in the Context of the Prediction of Breast Cancer Risk in Asia
    Soo-Hwang Teo (Cancer Research Malaysia, Malaysia)
ABC Networking Business Meeting
Venue: Weolla Room
  • Presentation about ABCN Collaborative Group
    Young-Jin Suh (The Catholic Univ. of Korea, St. Vincent's Hospital, Korea)
  • Presentation about ABCN Mentorship
    Hyeona Kim (Korea Cancer Center Hospital, Korea)
  • Wisdom Sharing for Asian Collaboration
    Louis Wing-Cheong Chow (Macau Univ. of Science and Technology, Macau)
16:10-17:20
Panel Discussion 4
Challenging Treatments for CNS Metastasis from Breast Cancer
Venue: Halla Hall
  • Current Challenges in Treating Breast Cancer Patients with Metastasis to Brain, Sneak Peak of Upcoming Biology
    Bora Lim (The Univ. of Texas, MD Anderson Cancer Center, U.S.A.)
  • Current Issues in the Management of Brain Metastases from Breast Cancer
    Kyubo Kim (Ewha Womans Univ. School of Medicine, Korea)
17:30-18:30
Dinner Symposium
Venue: Halla Hall
  • Determining the Optimal Adjuvant Chemotherapy for Lower or Intermediate Risk of Breast Cancer - Who Should Receive Adjuvant Chemotherapy?
    Kyoung Eun Lee (Ewha Womans Univ. Mokdong Hospital, Korea)
Back to Previous Meetings